Clinical Trial Update: Phase III, Randomized Trial: Lenalidomide vs Observation After Induction With Rituximab Followed by Cht and ASCT in MCL Adult Patients [Phase 3]

View source ↗

Summary

A Phase III randomized trial comparing lenalidomide versus observation after induction with rituximab followed by chemotherapy and autologous stem cell transpla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mantle Cell Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: MANTLE CELL LYMPHOMA | Phase 3 | Status: UNKNOWN